The author, a small business owner, expresses concern about the ongoing burden of prescription drug costs, which strain financial resources and hinder hiring. A recent survey by Small Business for America's Future revealed that 94% of small-business owners believe the current pricing market needs change. The author urges state lawmakers to prioritize appointments to the Drug Affordability Council to address the root causes of rising drug prices and ensure treatments remain accessible and affordable. The council can hold pharmaceutical companies accountable for price increases, lay the groundwork for long-term solutions, and relieve the financial burden of rising costs on small businesses by providing policy and regulatory recommendations. The impact of rising prescription drug costs on small businesses is daunting, and swift action is needed to alleviate this burden. It’s time for lawmakers to act decisively in the best interest of New Jersey’s small business owners.